PRELUDE CAPITAL MANAGEMENT, LLC - CARA THERAPEUTICS INC ownership

CARA THERAPEUTICS INC's ticker is CARA and the CUSIP is 140755109. A total of 70 filers reported holding CARA THERAPEUTICS INC in Q2 2016. The put-call ratio across all filers is 0.60 and the average weighting 0.3%.

Quarter-by-quarter ownership
PRELUDE CAPITAL MANAGEMENT, LLC ownership history of CARA THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$1,000
-83.3%
93
-80.6%
0.00%
Q4 2018$6,0000.0%479
+19.8%
0.00%
-100.0%
Q2 2017$6,000
-96.5%
400
-97.8%
0.00%
-95.2%
Q4 2016$172,000
+473.3%
18,521
+278.0%
0.02%
+425.0%
Q1 2016$30,000
-64.3%
4,900
-2.0%
0.00%
-69.2%
Q4 2015$84,000
+71.4%
5,000
+47.1%
0.01%
+85.7%
Q3 2015$49,0003,4000.01%
Other shareholders
CARA THERAPEUTICS INC shareholders Q2 2016
NameSharesValueWeighting ↓
Chescapmanager LLC 1,304,903$20,161,0002.86%
KINGDON CAPITAL MANAGEMENT, L.L.C. 715,684$11,057,0001.34%
DISCIPLINED GROWTH INVESTORS INC /MN 1,669,089$25,787,0000.51%
IQ EQ FUND MANAGEMENT (IRELAND) Ltd 156,625$2,420,0000.37%
ALPINE WOODS CAPITAL INVESTORS, LLC 184,632$2,853,0000.30%
Campbell & CO Investment Adviser LLC 42,600$658,0000.21%
FARALLON CAPITAL MANAGEMENT LLC 2,000,000$30,900,0000.14%
PDT Partners, LLC 104,648$1,617,0000.12%
Virtus ETF Advisers LLC 14,798$229,0000.10%
PINNACLE ASSOCIATES LTD 338,922$5,236,0000.10%
View complete list of CARA THERAPEUTICS INC shareholders